Progress and Comment on Surgical Treatment of Hepatoblastoma in Children

ZHAN Jianghua; WANG Zhiru

doi:10.3971/j.issn.1000-8578.2022.21.1476

Cancer Research on Prevention and Treatment > 2022 > 49(6): 541-545. > DOI: 10.3971/j.issn.1000-8578.2022.21.1476

ZHAN Jianghua, WANG Zhiru. Progress and Comment on Surgical Treatment of Hepatoblastoma in Children[J]. Cancer Research on Prevention and Treatment, 2022, 49(6): 541-545. DOI: 10.3971/j.issn.1000-8578.2022.21.1476

Citation:

PDF (3463 KB)

Progress and Comment on Surgical Treatment of Hepatoblastoma in Children

ZHAN Jianghua¹,
WANG Zhiru^{1, 2}

1.
Department of General Surgery, Tianjin Children's Hospital, Tianjin 300134, China
2.
Graduate College, Tianjin Medical University, Tianjin 300070, China

More Information

Received Date: December 16, 2021
Revised Date: January 21, 2022
Available Online: January 12, 2024

Graphical Abstract

Abstract

Abstract

Hepatoblastoma is the most common malignant tumor of liver in childhood. The onset of hepatoblastoma is insidious and the early symptoms are not typical. It is usually found in physical examination, mainly in the right lobe, and can involve several liver lobes. The tumor volume is often large when seeking treatment. In recent years, with the advancement of surgical techniques, the use of neoadjuvant chemotherapy drugs and the establishment of MDT teams, the survival rate of children with hepatoblastoma has been greatly improved. It's of great significance to select effective and reasonable treatment to improve the survival rate and the quality of life and reduce adverse reactions in children with hepatoblastoma. This paper reviews the progress of surgical treatment of hepatoblastoma in children.
- Hepatoblastoma,
- Surgical treatment,
- Liver transplantation,
- MDT,
- Prognosis

FullText(HTML)

References (32)

References

[1]	Feng J, Polychronidis G, Heger U, et al. Incidence trends and survival prediction of hepatoblastoma in children: a population-based study[J]. Cancer Commun (Lond), 2019, 39(1): 62. doi: 10.1186/s40880-019-0411-7
[2]	Lim ⅡP, Bondoc AJ, Geller JI, et al. Hepatoblastoma-The Evolution of Biology, Surgery, and Transplantation[J]. Children (Basel), 2018, 6(1): 1.
[3]	Hafberg E, Borinstein SC, Alexopoulos SP. Contemporary management of hepatoblastoma[J]. Curr Opin Organ Transplant, 2019, 24(2): 113-117. doi: 10.1097/MOT.0000000000000618
[4]	Kehm RD, Osypuk TL, Poynter JN, et al. Do pregnancy characteristics contribute to rising childhood cancer incidence rates in the United States?[J]. Pediatr Blood Cancer, 2018, 65(3): 10.
[5]	Yang T, Whitlock RS, Vasudevan SA. Surgical Management of Hepatoblastoma and Recent Advances[J]. Cancers (Basel), 2019, 11(12): 1944. doi: 10.3390/cancers11121944
[6]	儿童肝母细胞瘤诊疗规范(2019年版)编写审定专家组. 儿童肝母细胞瘤诊疗规范(2019年版)[J]. 临床肝胆病杂志, 2019, 35(11): 2431-2434. https://www.cnki.com.cn/Article/CJFDTOTAL-LCGD201911008.htm Compilation and Examination Expert Group for Guidelines for the Diagnosis and Treatment of Hepatoblastoma (2019). Guidelines for the diagnosis and treatment of hepatoblastoma (2019)[J]. Lin Chuang Gan Dan Bing Za Zhi, 2019, 35(11): 2431-2434. https://www.cnki.com.cn/Article/CJFDTOTAL-LCGD201911008.htm
[7]	廖雪莲, 蒋莎义, 杨静薇, 等. 基于甲胎蛋白临床诊断肝母细胞瘤行新辅助化疗可行性分析[J]. 临床儿科杂志, 2021, 39(8): 596-599. doi: 10.3969/j.issn.1000-3606.2021.08.009 Liao XL, Jiang SY, Yang JW, et al. Feasibility of the neoadjuvant chemotherapy for children with hepatoblastoma diagnosed by serum alpha-fetoprotein[J]. Lin Chuang Er Ke Za Zhi, 2021, 39(8): 596-599. doi: 10.3969/j.issn.1000-3606.2021.08.009
[8]	中华医学会病理学分会儿科病理学组, 福棠儿童医学发展研究中心病理专业委员会. 肝母细胞瘤病理诊断专家共识[J]. 中华病理学杂志, 2019, 48(3): 176-181. doi: 10.3760/cma.j.issn.0529-5807.2019.03.002 Group of Pediatric Pathology, Branch of Pathology, Chinese Medical Association; Pathology Specialist Committee of Futang Research Center of Pediatric Development. Chinese expert group consensus on pathological diagnosis of hepatoblastoma[J]. Zhonghua Bing Li Xue Za Zhi, 2019, 48(3): 176-181. doi: 10.3760/cma.j.issn.0529-5807.2019.03.002
[9]	Meyers RL, Maibach R, Hiyama E, et al. Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors International Collaboration[J]. Lancet Oncol, 2017, 18(1): 122-131. doi: 10.1016/S1470-2045(16)30598-8
[10]	Becker K, Furch C, Schmid I, et al. Impact of postoperative complications on overall survival of patients with hepatoblastoma[J]. Pediatr Blood Cancer, 2015, 62(1): 24-28. doi: 10.1002/pbc.25240
[11]	Czauderna P, Haeberle B, Hiyama E, et al. The Children's Hepatic tumors International Collaboration (CHIC): Novel global rare tumor database yields new prognostic factors in hepatoblastoma and becomes a research model[J]. Eur J Cancer, 2016, 52: 92-101. doi: 10.1016/j.ejca.2015.09.023
[12]	蔡耀华, 黄东生, 张谊. 儿童肝母细胞瘤的不同治疗策略[J]. 中国小儿血液与肿瘤杂志, 2020, 25(1): 53-56. doi: 10.3969/j.issn.1673-5323.2020.01.014 Cai YH, Huang DS, Zhang Y. Different therapeutic strategies for hepatoblastoma in children[J]. Zhongguo Xiao Er Xue Ye Yu Zhong Liu Za zhi, 2020, 25(1): 53-56. doi: 10.3969/j.issn.1673-5323.2020.01.014
[13]	韦源, 张现伟, 张飞, 等. 肝母细胞瘤肝切除术60例临床分析[J]. 河南外科学杂志, 2021, 27(1): 130-131. https://www.cnki.com.cn/Article/CJFDTOTAL-HLWK202101057.htm Wei Y, Zhang XW, Zhang F, et al. Clinical analysis of 60 cases of hepatectomy for hepatoblastoma[J]. He'nan Wai Ke Xue Za Zhi, 2021, 27(1): 130-131. https://www.cnki.com.cn/Article/CJFDTOTAL-HLWK202101057.htm
[14]	吴宙光, 王斌, 李守强, 等. 经导管动脉化疗栓塞术在婴幼儿肝母细胞瘤治疗中的应用[J]. 实用癌症杂志, 2020, 35(8): 1335-1338, 1350. doi: 10.3969/j.issn.1001-5930.2020.08.030 Wu ZG, Wang B, Li SQ, et al. Application Value of Transcatheter Arterial Chemoembolization in the Treatment of Infantile Hepatoblastoma[J]. Shi Yong Ai Zheng Za Zhi, 2020, 35(8): 1335-1338, 1350. doi: 10.3969/j.issn.1001-5930.2020.08.030
[15]	Jiang Y, Zhou S, Shen G, et al. Microwave ablation combined with transcatheter arterial chemoembolization is effective for treating unresectable hepatoblastoma in infants and children[J]. Medicine (Baltimore), 2018, 97(42): e12607. doi: 10.1097/MD.0000000000012607
[16]	Bertens KA, Hawel J, Lung K, et al. ALPPS: challenging the concept of unresectability-a systematic review[J]. Int J Surg, 2015, 13: 280-287. doi: 10.1016/j.ijsu.2014.12.008
[17]	姚伟, 董岿然, 肖现民, 等. 联合肝脏离断和门静脉结扎二步肝切除术治疗儿童肝母细胞瘤一例报告[J]. 中华小儿外科杂志, 2018, 39(8): 597-603. doi: 10.3760/cma.j.issn.0253-3006.2018.08.009 Yao W, Dong KR, Xiao XM, et al. Associating liver partition and portal vein ligation for staged hepatectomy for hepatoblastoma: a report of one case[J]. Zhonghua Xiao Er Wai Ke Za Zhi, 2018, 39(8): 597-603. doi: 10.3760/cma.j.issn.0253-3006.2018.08.009
[18]	董家鸿, 黄志强. 精准肝切除——21世纪肝脏外科新理念[J]. 中华外科杂志, 2009, 47(21): 1601-1605. doi: 10.3760/cma.j.issn.0529-5815.2009.21.001 Dong JH, Huang ZQ. Precise liver resection-new concept of liver surgery in 21st century[J]. Zhonghua Wai Ke Za Zhi, 2009, 47(21): 1601-1605. doi: 10.3760/cma.j.issn.0529-5815.2009.21.001
[19]	杨维, 任清华, 秦红, 等. 儿童肝母细胞瘤精准肝切除手术效果评价[J]. 临床小儿外科杂志, 2020, 19(5): 392-397. https://www.cnki.com.cn/Article/CJFDTOTAL-LCXR202005005.htm Yang W, Ren QH, Qin H, et al. Evaluation of the effect of precision hepatectomy in children with hepatoblastoma[J]. Lin Chuang Xiao Er Wai Ke Za Zhi, 2020, 19(5): 392-397. https://www.cnki.com.cn/Article/CJFDTOTAL-LCXR202005005.htm
[20]	Yamada Y, Ohno M, Fujino A, et al. Fluorescence-Guided Surgery for Hepatoblastoma with Indocyanine Green[J]. Cancers (Basel), 2019, 11(8): 1215. doi: 10.3390/cancers11081215
[21]	姚伟, 董岿然, 李凯, 等. 吲哚菁绿荧光显像技术在肝母细胞瘤精准切除手术中的应用[J]. 临床小儿外科杂志, 2019, 18(2): 107-111. doi: 10.3969/j.issn.1671-6353.2019.02.008 Yao W, Dong KR, Li K, et al. Application of indocyanine green fluorescence imagine technique in precise hepatectomy for hepatoblastoma[J]. Lin Chuang Xiao Er Wai Ke Za Zhi, 2019, 18(2): 107-111. doi: 10.3969/j.issn.1671-6353.2019.02.008
[22]	Paraboschi I, De Coppi P, Stoyanov D, et al. Fluorescence imaging in pediatric surgery: State-of-the-art and future perspectives[J]. J Pediatr Surg, 2021, 56(4): 655-662. doi: 10.1016/j.jpedsurg.2020.08.004
[23]	赵頔, 叶进冬, 李华丽, 等. 肝脏三维可视化重建技术在儿童复杂肝母细胞瘤肝切除术中的应用价值[J]. 临床肝胆病杂志, 2021, 37(9): 2130-2135. doi: 10.3969/j.issn.1001-5256.2021.09.025 Zhao D, Ye JD, Li HL, et al. Application of liver three-dimensional visualized reconstruction technique in hepatectomy for children with compli-cated hepatoblastoma[J]. Lin Chuang Gan Dan Bing Za Zhi, 2021, 37(9): 2130-2135. doi: 10.3969/j.issn.1001-5256.2021.09.025
[24]	Moosburner S, Schmelzle M, Schöning W, et al. Liver Transplantation Is Highly Effective in Children with Irresectable Hepatoblastoma[J]. Medicina (Kaunas), 2021, 57(8): 819. doi: 10.3390/medicina57080819
[25]	Hibi T, Rela M, Eason JD, et al. Liver Transplantation for Colorectal and Neuroendocrine Liver Metastases and Hepatoblastoma. Working Group Report From the ILTS Transplant Oncology Consensus Conference[J]. Transplantation, 2020, 104(6): 1131-1135. doi: 10.1097/TP.0000000000003118
[26]	Shi SJ, Wang DL, Hu W, et al. Ex vivo liver resection and autotransplantation with cardiopulmonary bypass for hepatoblastoma in children: A case report[J]. Pediatr Transplant, 2018, 22(7): e13268. doi: 10.1111/petr.13268
[27]	Schmelzle M, Krenzien F, Schöning W, et al. Laparoscopic liver resection: indications, limitations, and economic aspects[J]. Langenbecks Arch Surg, 2020, 405(6): 725-735. doi: 10.1007/s00423-020-01918-8
[28]	Akhaladze D, Merkulov N, Rabaev G. Laparoscopic-assisted extended right hepatectomy for hepatoblastoma in a child (Video)[J]. Surg Oncol, 2020, 34: 234-235. doi: 10.1016/j.suronc.2020.04.020
[29]	Wu Y, Zeng L, Qiu R, et al. Two-stage laparoscopic resection of giant hepatoblastoma in infants combined with liver partial partition and artery ligation[J]. World J Surg Oncol, 2021, 19(1): 63. doi: 10.1186/s12957-021-02156-y
[30]	曹迪, 柳龚堡, 史雨, 等. 儿童专科医院MDT模式建设实践探索[J]. 复旦学报(医学版), 2020, 47(4): 599-604. doi: 10.3969/j.issn.1672-8467.2020.04.022 Cao D, Liu GB, Shi Y, et al. Practical exploration of multi-disciplinary team (MDT) mode construction in children's hospital[J]. Fudan Xue Bao(Yi Xue Ban), 2020, 47(4): 599-604. doi: 10.3969/j.issn.1672-8467.2020.04.022
[31]	高阳旭, 孙青, 李辉, 等. 儿童肝母细胞瘤多学科协作模式下的治疗效果及临床成本[J]. 北京大学学报(医学版), 2021, 53(1): 200-203. https://www.cnki.com.cn/Article/CJFDTOTAL-BYDB202101031.htm Gao YX, Sun Q, Li H, et al. Therapeutic effect and clinical cost of multi-disciplinary team model of hepatoblastoma in children[J]. Beijing Da Xue Xue Bao (Yi Xue Ban), 2021, 53(1): 200-203. https://www.cnki.com.cn/Article/CJFDTOTAL-BYDB202101031.htm
[32]	Pearson KL, Hall NJ. What is the role of enhanced recovery after surgery in children? A scoping review[J]. Pediatr Surg Int, 2017, 33(1): 43-51. doi: 10.1007/s00383-016-3986-y

[1]	DONG Fei, PANG Meng, ZHENG Dong, ZHEN Jingfei, JING Hongmei. Clinical Characteristics and Prognosis of Primary Thyroid Lymphoma Patients[J]. Cancer Research on Prevention and Treatment, 2019, 46(6): 515-518. DOI: 10.3971/j.issn.1000-8578.2019.18.1561
[2]	JIN Long, FU Shenbo, YU Jiao. Effect of NLR and PLR from Pre-treatment on Prognosis of Nasopharyngeal Carcinoma Patients[J]. Cancer Research on Prevention and Treatment, 2017, 44(7): 476-480. DOI: 10.3971/j.issn.1000-8578.2017.16.1536
[3]	RONG Weiqi, WU Fan, YV Weibo, WU Jianxiong, WANG Liming, Tian Fei, AN Songlin, Feng Li. Comparison of Different Methods of Vascular Occlusion in Hepatectomy on Prognosis of Operable Small Liver Cancer Patients[J]. Cancer Research on Prevention and Treatment, 2015, 42(10): 1020-1023. DOI: 10.3971/j.issn.1000-8578.2015.10.015
[4]	LV Minhao, QIN Li, LI Juntao, GUO Xuhui, LIU Fawen, CUI Shude, ZHANG Hengwei. 原发性乳腺癌分子分型与新辅助化疗疗效及预后的相关性[J]. Cancer Research on Prevention and Treatment, 2015, 42(08): 782-788. DOI: 10.3971/j.issn.1000-8578.2015.08.007
[5]	LU Xianzhou, LIU Longfei, ZHOU Xiaojun, XIAO Shuai, LONG Jianwu, ZHOU Xian. GPR124 Expression and Its Relationship with Prognosis in Hepatocellular Carcinoma[J]. Cancer Research on Prevention and Treatment, 2014, 41(10): 1082-1086. DOI: 10.3971/j.issn.1000-8578.2014.10.006
[6]	MAO Zhiyuan, XIONG Mei, REN Li, LI Dechang, YUE Ying, ZHENG Jichun. Pathological Factors for Prognosis of Extrahepatic Cholangiocarcinoma[J]. Cancer Research on Prevention and Treatment, 2014, 41(07): 777-780. DOI: 10.3971/j.issn.1000-8578.2014.07.019
[7]	HE Lang, HOU Mei, LI Chang-lin, LI Guang-ming. Unsuitable Marker for PKCα to Predict Prognosis of Non-small Cell Lung Cancer[J]. Cancer Research on Prevention and Treatment, 2010, 37(01): 66-69. DOI: 10.3971/j.issn.1000-8578.2010.01.018
[8]	FU Wei-jin, WU Xiao-yun, MO Zeng-nan, YANG Zhan-bin. Diagnosis Treatment and Prognosis of Prostate Sarcoma (Report of 10 Cases)[J]. Cancer Research on Prevention and Treatment, 2009, 36(09): 772-774. DOI: 10.3971/j.issn.1000-8578.2009.09.016
[9]	GE Pei-lin, ZHONG Yun-ping. Prognosis Analysis of Low Grade Gliomas[J]. Cancer Research on Prevention and Treatment, 2005, 32(07): 438-439. DOI: 10.3971/j.issn.1000-8578.1262
[10]	WANG Jian-liu, Fu Qi, et al, . Treatment and Prognosis of Endometrial Carcinoma in Advanced Stage[J]. Cancer Research on Prevention and Treatment, 2001, 28(03): 214-216. DOI: 10.3971/j.issn.1000-8578.2150

Cited By

Get Citation

PDF

XML

Article views (2398) PDF downloads (1199)

Turn off MathJax

Article Contents

Abstract

References

Progress and Comment on Surgical Treatment of Hepatoblastoma in Children

Abstract

References

Related Articles

Catalog

Contact Us

Progress and Comment on Surgical Treatment of Hepatoblastoma in Children

Abstract

References

Related Articles

Catalog

Contact Us

Export File

Citation

Format

Content